[Antitubercular effect of capreomycin in vitro].
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology*; D019411:Clinical Laboratory Techniques; D004058:Diffusion; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects*; D009163:Mycobacterium bovis / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D014376:Tuberculosis / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D007538:Isoniazid; D013307:Streptomycin
Przeciwpratkowe właściwości kapreomycyny w badanich in vitro.